(a).

	Prednisone dispensed at visit					When medication dispensed should be used by patient
Visit name	(Additional prednisone may be dispensed at some study visits to allow for the maximum study visit window and duration between study visits)		IxRS reference	eCRF reference		Patient diary reference		Prednisone	Prednisone taken by patient at corresponding patient diary study week number
	Type	Comments		Visit folder	Study week number	Study week number	Wallet number∗ (taper week)∗ blinded part only		Type	Number per day	Number of tablets remaining	Medication returned at end of 7 days
Baseline		1 open label 10 mg bottle containing 100 tablets	Baseline to study week 1	Baseline	0	0	1	Open-label taper 60 mg/d		6 tablets per day	58 tablets remaining	No continue to use tablets in study week 1
			Study week 1 to study week 2	Week 1	1	1	2	Open-label taper 50 mg/d		5 tablets per day	23 tablets remaining	Yes return at study week 2 visit
Study week 1		1 open label 10 mg bottle containing 100 tablets	Study week 2 to study week 3	Week 2	2	2	3	Open-label taper 40 mg/d		4 tablets per day	72 tablets remaining	Yes return at study week 3 visit
Study week 2		2 open label 5 mg wallet (wallet contains 40 capsules)	Study week 3 to study week 4	Week 3	3	3	4	Open-label taper 35 mg/d		7 capsules per day	31 capsules remaining	No continue to use capsules in study week 4